Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P39
Within normal range
vs 2Y Ago
-1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -10.00% |
| Q2 2025 | 32.35% |
| Q1 2025 | -8.08% |
| Q4 2024 | -50.40% |
| Q3 2024 | -20.31% |
| Q2 2024 | 25.78% |
| Q1 2024 | 4.51% |
| Q4 2023 | -37.54% |
| Q3 2023 | 9.73% |
| Q2 2023 | -28.42% |
| Q1 2023 | 18.27% |
| Q4 2022 | -31.14% |
| Q3 2022 | -3.07% |
| Q2 2022 | 34.17% |
| Q1 2022 | 2.54% |
| Q4 2021 | 20.81% |
| Q3 2021 | -218.00% |
| Q2 2021 | 6.52% |
| Q1 2021 | -14.87% |
| Q4 2020 | -67933.30% |
| Q3 2020 | -128.44% |
| Q2 2020 | 98.51% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |